These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34816409)

  • 1. Testing Novel Inactivation Methods and Adjuvants for Vaccines Against Streptococcus agalactiae in Nile Tilapia Oreochromis niloticus.
    Ramos-Espinoza FC; Cueva-Quiroz VA; Yunis-Aguinaga J; Alvarez-Rubio NC; de Mello NP; de Moraes JRE
    Methods Mol Biol; 2022; 2411():241-249. PubMed ID: 34816409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of two adjuvants administrated with a novel hydrogen peroxide-inactivated vaccine against Streptococcus agalactiae in Nile tilapia fingerlings.
    Ramos-Espinoza FC; Cueva-Quiroz VA; Yunis-Aguinaga J; Alvarez-Rubio NC; Paganoti de Mello N; Engrácia de Moraes JR
    Fish Shellfish Immunol; 2020 Oct; 105():350-358. PubMed ID: 32717322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response and protective efficacy of two new adjuvants, Montanide™ ISA 763B VG and Montanide™ GEL02, administered with a Streptococcus agalactiae ghost vaccine in Nile tilapia (Oreochromis niloticus).
    Wangkaghart E; Deville S; Wang B; Srisapoome P; Wang T; Secombes CJ
    Fish Shellfish Immunol; 2021 Sep; 116():19-29. PubMed ID: 34153428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the efficacy of MONTANIDE™ GR01, a new adjuvant for feed-based vaccines, on the immune response and protection against Streptococcus agalactiae in oral vaccinated Nile tilapia (Oreochromis niloticus) under laboratory and on-farm conditions.
    Pholchamat S; Vialle R; Luang-In V; Phadee P; Wang B; Wang T; Secombes CJ; Wangkahart E
    Fish Shellfish Immunol; 2024 Jun; 149():109567. PubMed ID: 38641215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An effective live attenuated vaccine against Streptococcus agalactiae infection in farmed Nile tilapia (Oreochromis niloticus).
    Zhang D; Gao Y; Li Q; Ke X; Liu Z; Lu M; Shi C
    Fish Shellfish Immunol; 2020 Mar; 98():853-859. PubMed ID: 31751658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GapA, a potential vaccine candidate antigen against Streptococcus agalactiae in Nile tilapia (Oreochromis niloticus).
    Zhang Z; Yu A; Lan J; Zhang H; Hu M; Cheng J; Zhao L; Lin L; Wei S
    Fish Shellfish Immunol; 2017 Apr; 63():255-260. PubMed ID: 28219739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Streptococcus agalactiae vaccines for tilapia.
    Liu G; Zhu J; Chen K; Gao T; Yao H; Liu Y; Zhang W; Lu C
    Dis Aquat Organ; 2016 Dec; 122(2):163-170. PubMed ID: 28000606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of the effects of Montanide™ ISA 763A VG and ISA 763B VG adjuvants on the immune response against Streptococcus agalactiae in Nile tilapia (Oreochromis niloticus).
    Wangkahart E; Thongsrisuk A; Vialle R; Pholchamat S; Sunthamala P; Phudkliang J; Srisapoome P; Wang T; Secombes CJ
    Fish Shellfish Immunol; 2023 Mar; 134():108563. PubMed ID: 36717067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major surfome and secretome profile of Streptococcus agalactiae from Nile tilapia (Oreochromis niloticus): Insight into vaccine development.
    Li W; Wang HQ; He RZ; Li YW; Su YL; Li AX
    Fish Shellfish Immunol; 2016 Aug; 55():737-46. PubMed ID: 27327442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-immunity in Nile tilapia vaccinated with Streptococcus agalactiae and Streptococcus iniae vaccines.
    Wang Q; Fu T; Li X; Luo Q; Huang J; Sun Y; Wang X
    Fish Shellfish Immunol; 2020 Feb; 97():382-389. PubMed ID: 31841691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine-induced antibody level as the parameter of the influence of environmental salinity on vaccine efficacy in Nile tilapia.
    Wang J; He RZ; Lu GL; Luo HL; Lu DQ; Li AX
    Fish Shellfish Immunol; 2018 Nov; 82():522-530. PubMed ID: 30118846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic appraisal of vaccination against Streptoccocus agalactiae in Nile tilapia farms in Brazil.
    Delphino MKVC; Barone RSC; Leal CAG; Figueiredo HCP; Gardner IA; Gonçalves VSP
    Prev Vet Med; 2019 Jan; 162():131-135. PubMed ID: 30621892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of live attenuated Streptococcus agalactiae as potential vaccines by selecting for resistance to sparfloxacin.
    Pridgeon JW; Klesius PH
    Vaccine; 2013 May; 31(24):2705-12. PubMed ID: 23583891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of attenuated erythromycin-resistant Streptococcus agalactiae vaccine for tilapia (Oreochromis niloticus) culture.
    Liu L; Lu DQ; Xu J; Luo HL; Li AX
    J Fish Dis; 2019 May; 42(5):693-701. PubMed ID: 30893488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of intermittent hypoxia under different temperature on the immunomodulation in Streptococcus agalactiae vaccinated Nile tilapia (Oreochromis niloticus).
    Wang J; Lu DQ; Jiang B; Luo HL; Lu GL; Li AX
    Fish Shellfish Immunol; 2018 Aug; 79():181-192. PubMed ID: 29684601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant lactococcal-based oral vaccine for protection against Streptococcus agalactiae infections in tilapia (Oreochromis niloticus).
    Wong KY; Megat Mazhar Khair MH; Song AAL; Masarudin MJ; Loh JY; Chong CM; Beardall J; Teo MYM; In LLA
    Fish Shellfish Immunol; 2024 Jun; 149():109572. PubMed ID: 38636739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of live attenuated vaccine derived from the Streptococcus agalactiae on the immune responses of Oreochromis niloticus.
    Laith AA; Abdullah MA; Nurhafizah WWI; Hussein HA; Aya J; Effendy AWM; Najiah M
    Fish Shellfish Immunol; 2019 Jul; 90():235-243. PubMed ID: 31009810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity in Oreochromis niloticus vaccinated with sonicated antigens against streptococcosis.
    Marcusso PF; da Silva Claudiano G; Yunis-Aguinaga J; de Almeida Marinho-Neto F; Eto SF; Fernandes DC; Rosolem MC; Salvador R; Engracia de Moraes JR; Ruas de Moraes F
    Fish Shellfish Immunol; 2021 Aug; 115():134-141. PubMed ID: 34098067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passive immunization of Nile tilapia (Oreochromis niloticus) provides significant protection against Streptococcus agalactiae.
    Pasnik DJ; Evans JJ; Klesius PH
    Fish Shellfish Immunol; 2006 Oct; 21(4):365-71. PubMed ID: 16531069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of novel antigenic vaccine candidates for nile tilapia (Oreochromis niloticus) against Streptococcus agalactiae infection.
    Ma Y; Hao L; Liang Z; Ma J; Ke H; Kang H; Yang H; Wu J; Feng G; Liu Z
    Fish Shellfish Immunol; 2020 Oct; 105():405-414. PubMed ID: 32712231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.